For instance, everolimus, an inhibitor of mTOR which is used for treatment of tumor manifestations in patients with tuberous sclerosis complex also provide impressive therapeutic effect on improving neuropsychiatric symptoms (Kilincaslan et al., 2017). This evidence concerns the gene MTOR and tuberous sclerosis.